메뉴 건너뛰기




Volumn 27, Issue 4, 2007, Pages 99-103

Glycemic control in patients of chronic kidney disease

Author keywords

Diabetes; Glycemic control; Kidney disease

Indexed keywords


EID: 38949099020     PISSN: 09733930     EISSN: None     Source Type: Journal    
DOI: 10.4103/0973-3930.38627     Document Type: Review
Times cited : (1)

References (17)
  • 1
    • 0031764799 scopus 로고    scopus 로고
    • Hyperglycemia and intensive glycemic control in diabetic patients with chronic renal disease
    • Manske CL. Hyperglycemia and intensive glycemic control in diabetic patients with chronic renal disease. Am J Kidney Dis 1998;32:S157-71.
    • (1998) Am J Kidney Dis , vol.32
    • Manske, C.L.1
  • 3
    • 0030944242 scopus 로고    scopus 로고
    • A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients
    • Rigalleau V, Blanchetier V, Combe C, Guillot C, Deleris G, Aubertin J, et al. A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients. Am J Clin Nutr 1997;65:1512-6.
    • (1997) Am J Clin Nutr , vol.65 , pp. 1512-1516
    • Rigalleau, V.1    Blanchetier, V.2    Combe, C.3    Guillot, C.4    Deleris, G.5    Aubertin, J.6
  • 5
    • 20844435106 scopus 로고    scopus 로고
    • Oral antihyperglycemic agents and renal disease: New agents, new concepts
    • Yale JF. Oral antihyperglycemic agents and renal disease: New agents, new concepts. J Am Soc Nephrol 2005;16:S7-10.
    • (2005) J Am Soc Nephrol , vol.16
    • Yale, J.F.1
  • 6
    • 33845760213 scopus 로고    scopus 로고
    • KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease
    • KDOQI
    • KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49:S12-154.
    • (2007) Am J Kidney Dis , vol.49
  • 7
    • 0026771083 scopus 로고
    • Glucose and insulin metabolism in uremia
    • Mak RH, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992;61:377-82.
    • (1992) Nephron , vol.61 , pp. 377-382
    • Mak, R.H.1    DeFronzo, R.A.2
  • 8
    • 31544464630 scopus 로고    scopus 로고
    • Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus
    • Ersoy A, Ersoy C, Altinay T. Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus. Nephrol Dial Transplant 2006;21:553-4.
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 553-554
    • Ersoy, A.1    Ersoy, C.2    Altinay, T.3
  • 9
    • 0037373850 scopus 로고    scopus 로고
    • Assessing glycemic control in patients with diabetes and end-stage renal failure
    • Ansari A, Thomas S, Goldsmith D. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis 2003;41:523-31.
    • (2003) Am J Kidney Dis , vol.41 , pp. 523-531
    • Ansari, A.1    Thomas, S.2    Goldsmith, D.3
  • 10
    • 4444369757 scopus 로고    scopus 로고
    • Hypoglycemic coma in a diabetic patient on peritoneal dialysis due to interference of icodextrin metabolites with capillary blood glucose measurements
    • Disse E, Thivolet C. Hypoglycemic coma in a diabetic patient on peritoneal dialysis due to interference of icodextrin metabolites with capillary blood glucose measurements. Diabetes Care 2004;27:2279.
    • (2004) Diabetes Care , vol.27 , pp. 2279
    • Disse, E.1    Thivolet, C.2
  • 11
    • 0035656524 scopus 로고    scopus 로고
    • Insulin therapy during peritoneal dialysis: Pros and cons of various forms of administration
    • Quellhorst E. Insulin therapy during peritoneal dialysis: Pros and cons of various forms of administration. J Am Soc Nephrol 2002;13:S92-6.
    • (2002) J Am Soc Nephrol , vol.13
    • Quellhorst, E.1
  • 12
    • 0035347825 scopus 로고    scopus 로고
    • Glycemic control is a predictor of survival for diabetic patients on hemodialysis
    • Morioka T, Emoto M, Tabata T, Shoji T, Tahara H, Kishimoto H, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 2001;24:909-13.
    • (2001) Diabetes Care , vol.24 , pp. 909-913
    • Morioka, T.1    Emoto, M.2    Tabata, T.3    Shoji, T.4    Tahara, H.5    Kishimoto, H.6
  • 13
    • 33645231696 scopus 로고    scopus 로고
    • The effect of glucose added to the dialysis fluid on blood pressure, blood glucose and quality of life in hemodialysis patients: A placebo-controlled crossover study
    • Sangill M, Pedersen EB. The effect of glucose added to the dialysis fluid on blood pressure, blood glucose and quality of life in hemodialysis patients: A placebo-controlled crossover study. Am J Kidney Dis 2006,47:636-43.
    • (2006) Am J Kidney Dis , vol.47 , pp. 636-643
    • Sangill, M.1    Pedersen, E.B.2
  • 14
    • 0020526172 scopus 로고
    • Reversible diminished insulin requirement during acute renal failure
    • Naschitz JE, Barak C, Yeshurun D. Reversible diminished insulin requirement during acute renal failure. Postgrad Med J 1983;59:269-71.
    • (1983) Postgrad Med J , vol.59 , pp. 269-271
    • Naschitz, J.E.1    Barak, C.2    Yeshurun, D.3
  • 15
    • 11244340690 scopus 로고    scopus 로고
    • Van Hooff JP, Christiaans MH, van Duijnhoven EM. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant 2004;19:vi8-12.
    • Van Hooff JP, Christiaans MH, van Duijnhoven EM. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant 2004;19:vi8-12.
  • 16
    • 0029898777 scopus 로고    scopus 로고
    • Diabetes in dialysis patients: When diabetes is not diabetic nephropathy
    • Catalano C. Diabetes in dialysis patients: when diabetes is not diabetic nephropathy. Nephrol Dial Transplant 1996;11:938-41.
    • (1996) Nephrol Dial Transplant , vol.11 , pp. 938-941
    • Catalano, C.1
  • 17
    • 33845367689 scopus 로고    scopus 로고
    • Drug interactions of medications commonly used in diabetes
    • Triplitt C. Drug interactions of medications commonly used in diabetes. Diabetes Spectrum 2006;19:202-11.
    • (2006) Diabetes Spectrum , vol.19 , pp. 202-211
    • Triplitt, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.